Technical Analysis for LABS - Medipharm Labs Corp.

Grade Last Price % Change Price Change
grade B 6.46 1.73% 0.110
LABS closed up 1.73 percent on Friday, May 24, 2019, on 68 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Down
See historical LABS trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
MACD Bearish Signal Line Cross Bearish 1.73%
Wide Bands Range Expansion 1.73%
Wide Bands Range Expansion -7.45%
Overbought Stochastic Strength -7.45%
Outside Day Range Expansion -6.10%
Wide Bands Range Expansion -6.10%
Overbought Stochastic Strength -6.10%
Narrow Range Bar Range Contraction -8.24%

Older signals for LABS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
MediPharm Labs, through its subsidiary, is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.
Medicine Cannabis Entheogens Euphoriants Medicinal Plants Herbalism Medical Cannabis Health Sciences Pharmaceuticals Policy Cannabis In Canada Legality Of Cannabis Business To Business Access To Cannabis For Medical Purposes Regulations Licensed Producer Licensed Producers Medical Cannabis Products
Is LABS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 7.39
52 Week Low 0.91
Average Volume 1,546,233
200-Day Moving Average 0.0
50-Day Moving Average 4.9986
20-Day Moving Average 6.165
10-Day Moving Average 6.734
Average True Range 0.4912
ADX 34.24
+DI 26.7413
-DI 20.1134
Chandelier Exit (Long, 3 ATRs ) 5.9164
Chandelier Exit (Short, 3 ATRs ) 6.6136
Upper Bollinger Band 7.4503
Lower Bollinger Band 4.8797
Percent B (%b) 0.61
BandWidth 41.696675
MACD Line 0.5032
MACD Signal Line 0.5553
MACD Histogram -0.0521
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.075
Resistance 3 (R3) 7.103 6.927 6.973
Resistance 2 (R2) 6.927 6.770 6.913 6.938
Resistance 1 (R1) 6.693 6.673 6.665 6.665 6.904
Pivot Point 6.517 6.517 6.503 6.503 6.517
Support 1 (S1) 6.283 6.360 6.255 6.255 6.016
Support 2 (S2) 6.107 6.263 6.093 5.982
Support 3 (S3) 5.873 6.107 5.948
Support 4 (S4) 5.845